Tosk's Unattributed Round

Tosk raised a round of funding on March 28, 2016.

Tosk is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis and Crohn's Disease. Tosk employs m…

Articles about Tosk's Unattributed Round: